2024 annual financial data
Compass Therapeutics 2024 Operating cash flow
Direct answer
Operating cash flow was -44,855,000 USD.
Operating income was -56,625,000 USD and net income was -49,375,000 USD.
Operating cash flow was -44,855,000 USD.
Get free Compass Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 850,000 USD
- Operating income
- -56,625,000 USD
- Net income
- -49,375,000 USD
- Operating cash flow
- -44,855,000 USD